Zhi Dong

483 total citations
11 papers, 334 citations indexed

About

Zhi Dong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Zhi Dong has authored 11 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Zhi Dong's work include Cancer Immunotherapy and Biomarkers (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and Air Quality and Health Impacts (1 paper). Zhi Dong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and Air Quality and Health Impacts (1 paper). Zhi Dong collaborates with scholars based in China, United States and Hong Kong. Zhi Dong's co-authors include Christian C. Abnet, Steven D. Mark, You‐Lin Qiao, Philip R. Taylor, Sanford M. Dawsey, Lin Song, Xuewen Tang, Yuntao Jia, Huanhuan Ji and D Ratnasinghe and has published in prestigious journals such as Scientific Reports, Pediatric Research and Cancer Causes & Control.

In The Last Decade

Zhi Dong

10 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhi Dong China 6 122 112 92 86 64 11 334
Merica Glavina Durdov Croatia 13 194 1.6× 73 0.7× 31 0.3× 61 0.7× 94 1.5× 48 420
Mohammed T. Tayeb Saudi Arabia 12 135 1.1× 87 0.8× 32 0.3× 59 0.7× 67 1.0× 22 361
Lixia Wang China 12 142 1.2× 45 0.4× 47 0.5× 63 0.7× 44 0.7× 24 379
Xiaochun Zhu China 13 81 0.7× 32 0.3× 115 1.3× 62 0.7× 57 0.9× 23 369
Yujue He China 8 96 0.8× 83 0.7× 94 1.0× 17 0.2× 32 0.5× 14 311
Satish Kumar Devarapu Germany 11 120 1.0× 45 0.4× 66 0.7× 42 0.5× 28 0.4× 17 384
Dominik Majewski Poland 10 88 0.7× 38 0.3× 120 1.3× 36 0.4× 15 0.2× 31 325
Chia‐Chun Tseng Taiwan 11 128 1.0× 24 0.2× 83 0.9× 30 0.3× 20 0.3× 25 304

Countries citing papers authored by Zhi Dong

Since Specialization
Citations

This map shows the geographic impact of Zhi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Dong more than expected).

Fields of papers citing papers by Zhi Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Dong. The network helps show where Zhi Dong may publish in the future.

Co-authorship network of co-authors of Zhi Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Dong. A scholar is included among the top collaborators of Zhi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Dong. Zhi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Yida, Tianzhuo Zhang, Xue Yang, et al.. (2021). Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients. Annals of Translational Medicine. 9(1). 33–33. 24 indexed citations
2.
Ji, Huanhuan, Xuewen Tang, Zhi Dong, Lin Song, & Yuntao Jia. (2019). Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS. Clinical Drug Investigation. 39(3). 319–330. 88 indexed citations
3.
Zhuo, Minglei, Qiwen Zheng, Jun Zhao, et al.. (2017). Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysis. Chinese Journal of Cancer Research. 29(6). 553–560. 10 indexed citations
4.
Dong, Zhi, Jing Chen, Ye Chun Ruan, et al.. (2015). CFTR-regulated MAPK/NF-κB signaling in pulmonary inflammation in thermal inhalation injury. Scientific Reports. 5(1). 15946–15946. 40 indexed citations
5.
Wang, Xiaoyan, Zeng-Chun Ma, Shuai Shao, et al.. (2014). Radioprotective effect of adenine on irradiation-induced apoptosis. Chinese Journal of Natural Medicines. 11(2). 139–144. 3 indexed citations
6.
Zhang, Hua, et al.. (2012). The effect of the strong magnetic field on the process of ignition in the magnetized plasma. 40. 1–8. 1 indexed citations
7.
Liu, Yuan, et al.. (2012). [Establishment of a high throughput screening model of cannabinoid receptor 2 agonist].. PubMed. 28(2). 194–6. 2 indexed citations
8.
Dong, Zhi. (2004). The study on the experiment of hepatocarcinoma with homogenous spleenocytes activated by IL-2 and Tremella Polysaccharide. Zhongguo mianyixue zazhi. 2 indexed citations
9.
Roth, Mark J., Christian C. Abnet, Laura Lee Johnson, et al.. (2004). Polymorphic variation of CYP1A1 is associated with the risk of gastric cardia cancer: a prospective case?cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes & Control. 15(10). 1077–1083. 48 indexed citations
10.
Stolzenberg‐Solomon, Rachael Z., You‐Lin Qiao, Christian C. Abnet, et al.. (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China.. PubMed. 12(11 Pt 1). 1222–6. 114 indexed citations
11.
Black, Stephen M., Jeffrey R. Fineman, Michael Johengen, Zhi Dong, & Scott J. Soifer. (1996). ALTERATIONS IN PULMONARY BLOOD FLOW IN THE LAMB INDUCES CHANGES IN PULMONARY VASCULAR MORPHOLOGY AND GROWTH FACTOR EXPRESSION. • 121. Pediatric Research. 39. 23–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026